CorMedix Inc (NASDAQ: CRMD) stock closed at $12.16 on 10/20/25 after a major increase of 19.4%. Moreover, trading volume in this advance was exceptionally high at 234% of normal. The stock has risen 13.3% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CorMedix has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. CorMedix has a slightly positive Power Rating of 66 and a very high Appreciation Score of 99, producing the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment